chartexchange

BDTX
Black Diamond Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 17, 2026 11:36:13 AM EST
1.45USD-5.229%(-0.08)293,419
Pre-marketNov 17, 2026 9:25:30 AM EST
1.5024USD-1.804%(-0.0276)
1.4400Bid1.4600Ask0.0200Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$1.52
Beta
1.75
52-Week High
$4.20 2025-11-17
52-Week Low
$1.40 2026-11-16
SMA 50
$1.84
SMA 200
$2.14
Avg. Vol 10D
751,775
Avg. Vol 30D
849,785
Avg. Vol 90D
691,449
Relative Vol
0.33
46.17M
0.5000%
1,100,000
12,177
BDTX Profile

black diamond therapeutics, inc., a precision oncology medicine company, discovers and develops small molecule, tumor-agnostic therapies. its lead product candidate is bdtx-189, an inhibitor of non-canonical and oncogenic mutations of erbb kinases epidermal growth factor receptor (egfr) and tyrosine-protein kinase. the company is also developing allosteric-egfr mutation inhibitors; and various early stage pipeline programs targeting allosteric mutations in kinases related to cancer and/or rare genetic diseases. the company was formerly known as aset therapeutics, inc. and changed its name to black diamond therapeutics, inc. in january 2018. black diamond therapeutics, inc. was founded in 2014 and is headquartered in cambridge, massachusetts.

BDTX Performance
PeriodPriceDateChangeBeta
1W1.602026-11-10-8.78%-0.891
1M1.722026-10-16-15.41%2.519
3M2.052026-08-17-29.02%2.117
6M2.582026-05-18-43.60%1.465
1Y4.012025-11-17-63.72%1.754
2Y2.502024-11-18-41.80%—
5Y7.602021-11-17-80.86%1.668
BDTX Stock Summary

Black Diamond Therapeutics, Inc. Common Stock (NASDAQ:BDTX) stock price today is $1.46, and today's volume is 280,979. BDTX is down 4.902% today. The 30 day average volume is 849,785. BDTX market cap is $83.62M with 57.47M shares outstanding.